Journal of the American College of Cardiology
Volume 50, Issue 11, 11 September 2007, Pages 1054-1060
Clinical ResearchHeart FailurePrognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure
Heart Failure
Under an Elsevier user license
open archive
Abbreviations and Acronyms
BNP
B-type natriuretic peptide
CHF
chronic heart failure
GDF-15
growth differentiation factor-15
LVEF
left ventricular ejection fraction
NT-proBNP
amino-terminal pro–B-type natriuretic peptide
NYHA
New York Heart Association
ROC
receiver-operating characteristic
Cited by (0)
This study was supported by grants from the German Research Foundation (to Dr. Wollert) and the German Heart Failure Network (to Drs. Wollert and Anker).
The first two authors contributed equally to this work.
- 1
Drs. Kempf, Drexler, and Wollert have filed a patent for and have a contract with Roche Diagnostics to develop a commercial assay for GDF-15 used for diagnosis and prognosis in cardiovascular disease.
Copyright © 2007 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.